BRIDGEWATER, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, manufacturer of fecal immunochemical tests for colorectal cancer screening programs, announces that in a study of more than 1000 ...
The InSure FIT and the FOBT accounted for 56 percent of all new screenings. Because a colonoscopy with normal findings is generally only completed every ten years for a person of average risk, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback